[New oral anticoagulants in perioperative medicine]

A Giebl1, K Gürtler

  • 1Institut für Transfusionsmedizin und Hämostaseologie, Klinikum Augsburg, Augsburg, Deutschland.

Der Anaesthesist
|April 4, 2014
PubMed

Insights

New oral anticoagulants (NOACs) require careful perioperative management due to bleeding risks. Early anesthesiologist evaluation and interdisciplinary approaches are crucial for safe surgical planning and emergency procedures.

Area of Science:

  • Pharmacology and Hematology
  • Anesthesiology and Perioperative Medicine

Context:

  • New oral anticoagulants (NOACs) are increasingly used as alternatives to vitamin K antagonists for various indications.
  • Perioperative management of patients on NOACs presents significant challenges across medical disciplines.
  • Indications include deep vein thrombosis prophylaxis, therapeutic anticoagulation, and stroke prophylaxis in atrial fibrillation.

Purpose:

  • To outline the perioperative challenges associated with NOACs.
  • To emphasize the need for early anesthesiologist evaluation for non-emergency surgeries.
  • To highlight the importance of an interdisciplinary approach for managing emergency procedures.

Summary:

  • NOACs inhibit factor Xa or factor IIa, posing challenges for perioperative care.
  • Non-emergency surgery requires early anesthesiologist consultation for optimal scheduling and bridging strategies.
  • Emergency procedures necessitate individualized risk assessment (bleeding vs. urgency) and may involve drug serum level determination.

Impact:

  • Informed perioperative strategies for patients on NOACs can mitigate bleeding risks.
  • Facilitates safer surgical planning and execution for patients requiring anticoagulation.
  • Guides management of coagulopathy during emergency procedures, including the use of blood products and factor concentrates.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
621
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460